173 related articles for article (PubMed ID: 37943631)
21. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis.
Carter JM; Howe BM; Hawse JR; Giannini C; Spinner RJ; Fritchie KJ
Am J Surg Pathol; 2016 Oct; 40(10):1368-74. PubMed ID: 27259010
[TBL] [Abstract][Full Text] [Related]
22. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
[TBL] [Abstract][Full Text] [Related]
23. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm.
Wang WL; Nero C; Pappo A; Lev D; Lazar AJ; López-Terrada D
Pediatr Dev Pathol; 2012; 15(5):361-7. PubMed ID: 22372443
[TBL] [Abstract][Full Text] [Related]
24. Desmoid tumor: a disease opportune for molecular insights.
Kotiligam D; Lazar AJ; Pollock RE; Lev D
Histol Histopathol; 2008 Jan; 23(1):117-26. PubMed ID: 17952864
[TBL] [Abstract][Full Text] [Related]
25. Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.
Mignemi NA; Itani DM; Fasig JH; Keedy VL; Hande KR; Whited BW; Homlar KC; Correa H; Coffin CM; Black JO; Yi Y; Halpern JL; Holt GE; Schwartz HS; Schoenecker JG; Cates JM
Cancer Sci; 2012 Dec; 103(12):2173-80. PubMed ID: 23035734
[TBL] [Abstract][Full Text] [Related]
26. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S
Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757
[TBL] [Abstract][Full Text] [Related]
27. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
Heinrich MC; McArthur GA; Demetri GD; Joensuu H; Bono P; Herrmann R; Hirte H; Cresta S; Koslin DB; Corless CL; Dirnhofer S; van Oosterom AT; Nikolova Z; Dimitrijevic S; Fletcher JA
J Clin Oncol; 2006 Mar; 24(7):1195-203. PubMed ID: 16505440
[TBL] [Abstract][Full Text] [Related]
28. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
[TBL] [Abstract][Full Text] [Related]
29. Desmoid Fibromatosis With TP53 Mutation and Striking Nuclear Pleomorphism.
Foster CR; Strauss M; Hornick JL; Habeeb O
Int J Surg Pathol; 2023 Dec; 31(8):1565-1571. PubMed ID: 36908221
[TBL] [Abstract][Full Text] [Related]
30. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical evaluation of potential molecular targets of desmoid-type fibromatosis.
Janegova A; Hlavata Z; Mihok L; Copakova L; Babal P; Janega P
Pol J Pathol; 2021; 72(3):252-260. PubMed ID: 35048638
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
[TBL] [Abstract][Full Text] [Related]
33. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
Signoroni S; Frattini M; Negri T; Pastore E; Tamborini E; Casieri P; Orsenigo M; Da Riva L; Radice P; Sala P; Gronchi A; Bertario L; Pierotti MA; Pilotti S
Clin Cancer Res; 2007 Sep; 13(17):5034-40. PubMed ID: 17785554
[TBL] [Abstract][Full Text] [Related]
35. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous desmoid-type fibromatosis: A rare case with molecular profiling.
Aghighi M; Cloutier JM; Hoover WD; Roy K; Lo AA; Brown RA
J Cutan Pathol; 2021 Sep; 48(9):1185-1188. PubMed ID: 33978242
[TBL] [Abstract][Full Text] [Related]
37. Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis.
Prete F; Rotelli M; Stella A; Calculli G; Sgaramella LI; Amati A; Resta N; Testini M; Gurrado A
Clin Exp Med; 2023 Jul; 23(3):607-617. PubMed ID: 35913675
[TBL] [Abstract][Full Text] [Related]
38. A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.
Poon R; Hong H; Wei X; Pan J; Alman BA
PLoS One; 2012; 7(5):e37940. PubMed ID: 22666417
[TBL] [Abstract][Full Text] [Related]
39. TGF-β signaling promotes desmoid tumor formation via CSRP2 upregulation.
Li Y; Fujishita T; Mishiro-Sato E; Kojima Y; Niu Y; Taketo MM; Urano Y; Sakai T; Enomoto A; Nishida Y; Aoki M
Cancer Sci; 2024 Feb; 115(2):401-411. PubMed ID: 38041233
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Wnt/Beta catenin signalling in desmoid tumors.
Tejpar S; Michils G; Denys H; Van Dam K; Nik SA; Jadidizadeh A; Cassiman JJ
Acta Gastroenterol Belg; 2005; 68(1):5-9. PubMed ID: 15832580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
